situation selection Search Results


pcc 7002  (ATCC)
95
ATCC pcc 7002
Pcc 7002, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/situation+selection/Hs+1%2ETes/bio_rxiv__2024__12__11__628068-117-18-28
Average 95 stars, based on 1 article reviews
pcc 7002 - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier
cteph ecs  (ATCC)
92
ATCC cteph ecs
(A) Schematic drawing depicting the analysis of <t>CTEPH‐ECs,</t> HPAECs, and HSaVECs. The panel was created with BioRender.com. (B) TMEM100 mRNA expression in CTEPH‐ECs ( n = 20 biological replicates; ECs isolated from central PEA samples marked with “full” and distal PEA samples with “open” circles) compared to HPAECs ( n = 3 biological replicates examined in 3–6 independent experiments) and HSaVECs ( n = 1 biological replicate examined in four independent experiments). (C and D) TMEM100 protein expression in CTEPH‐ECs ( n = 3 biological replicates examined in 3 independent experiments), HPAECs ( n = 2 biological replicates examined in 2 – 3 independent experiments), and HSaVECs ( n = 1 biological replicate examined in 5 independent experiments). Quantitative analysis (C). Representative images (D). Expression of CD31/PECAM1 is shown to demonstrate EC marker expression. (E and F) Immunohistochemical detection of TMEM100 on cross‐sections through PEA specimens from patients with CTEPH ( n = 6 biological replicates) or PE ( n = 3 biological replicates examined in 2 independent experiments). Representative images (E). Quantitative analysis (F). Findings after omission of the first antibody (negative control) are also shown. ALK1 (G) and ALK5 (H) mRNA expression in CTEPH‐ECs ( n = 12 and n = 8 biological replicates, respectively) versus HPAECs ( n = 3 biological replicates examined in 2–3 independent experiments) and HSaVECs ( n = 1 biological replicate examined in 5 independent experiments). (I) TMEM100 mRNA expression in HPAECs ( n = 2 biological replicates examined in 2 independent experiments), control or after TGFβ1 stimulation (10 ng/mL for 24 h), alone or in the presence of the ALK1 inhibitor K02288 (10 µM) or the ALK5 inhibitor SB431542 (10 µM). ALK1 (J) and ALK5 (K) mRNA expression in HPAECs ( n = 2 biological replicates examined in 3 independent experiments), control or after TGFβ1 stimulation, and TMEM100 siRNA transfection. ALK1 (L) and ALK5 (M) mRNA expression in HPAECs ( n = 2 biological replicates examined in 2–3 independent experiments), alone or in the presence of an ALK5 (L) or ALK1 (M) inhibitor. Representative images (N) and quantitative analysis of the cumulative tube length (O) of CTEPH‐ECs ( n = 1 biological replicate examined in 4 independent experiments) cultivated on Matrigel for 5 h and the effects of TGFβ1 stimulation (10 ng/mL for 24 h), control or TMEM100 siRNA transfection, ALK1, or ALK5 inhibition. Exact p values were determined using unpaired Student's t ‐test (F, L, and M), one‐way ANOVA, Sidak's multiple comparisons test (G, H, I, and O), or Kruskal–Wallis, Dunn's multiple comparisons test (B, C, J, and K), based on the Shapiro–Wilk test for normal distribution. Quantitative data are shown as mean ± SEM or median with interquartile range, depending on the presence of normal distribution or not. Scale bars in (D), (E), and (N) denote 100 µm. (P) Visual summary of the findings of the study. The panel was created with Inkscape v.1.4.2.
Cteph Ecs, supplied by ATCC, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/situation+selection/Streptomyces+longisporoflavus+Waksman/pmc12852499-12-0-36
Average 92 stars, based on 1 article reviews
cteph ecs - by Bioz Stars, 2026-10
92/100 stars
  Buy from Supplier
induction with thioglycolate tgc medium  (ATCC)
90
ATCC induction with thioglycolate tgc medium
(A) Schematic drawing depicting the analysis of <t>CTEPH‐ECs,</t> HPAECs, and HSaVECs. The panel was created with BioRender.com. (B) TMEM100 mRNA expression in CTEPH‐ECs ( n = 20 biological replicates; ECs isolated from central PEA samples marked with “full” and distal PEA samples with “open” circles) compared to HPAECs ( n = 3 biological replicates examined in 3–6 independent experiments) and HSaVECs ( n = 1 biological replicate examined in four independent experiments). (C and D) TMEM100 protein expression in CTEPH‐ECs ( n = 3 biological replicates examined in 3 independent experiments), HPAECs ( n = 2 biological replicates examined in 2 – 3 independent experiments), and HSaVECs ( n = 1 biological replicate examined in 5 independent experiments). Quantitative analysis (C). Representative images (D). Expression of CD31/PECAM1 is shown to demonstrate EC marker expression. (E and F) Immunohistochemical detection of TMEM100 on cross‐sections through PEA specimens from patients with CTEPH ( n = 6 biological replicates) or PE ( n = 3 biological replicates examined in 2 independent experiments). Representative images (E). Quantitative analysis (F). Findings after omission of the first antibody (negative control) are also shown. ALK1 (G) and ALK5 (H) mRNA expression in CTEPH‐ECs ( n = 12 and n = 8 biological replicates, respectively) versus HPAECs ( n = 3 biological replicates examined in 2–3 independent experiments) and HSaVECs ( n = 1 biological replicate examined in 5 independent experiments). (I) TMEM100 mRNA expression in HPAECs ( n = 2 biological replicates examined in 2 independent experiments), control or after TGFβ1 stimulation (10 ng/mL for 24 h), alone or in the presence of the ALK1 inhibitor K02288 (10 µM) or the ALK5 inhibitor SB431542 (10 µM). ALK1 (J) and ALK5 (K) mRNA expression in HPAECs ( n = 2 biological replicates examined in 3 independent experiments), control or after TGFβ1 stimulation, and TMEM100 siRNA transfection. ALK1 (L) and ALK5 (M) mRNA expression in HPAECs ( n = 2 biological replicates examined in 2–3 independent experiments), alone or in the presence of an ALK5 (L) or ALK1 (M) inhibitor. Representative images (N) and quantitative analysis of the cumulative tube length (O) of CTEPH‐ECs ( n = 1 biological replicate examined in 4 independent experiments) cultivated on Matrigel for 5 h and the effects of TGFβ1 stimulation (10 ng/mL for 24 h), control or TMEM100 siRNA transfection, ALK1, or ALK5 inhibition. Exact p values were determined using unpaired Student's t ‐test (F, L, and M), one‐way ANOVA, Sidak's multiple comparisons test (G, H, I, and O), or Kruskal–Wallis, Dunn's multiple comparisons test (B, C, J, and K), based on the Shapiro–Wilk test for normal distribution. Quantitative data are shown as mean ± SEM or median with interquartile range, depending on the presence of normal distribution or not. Scale bars in (D), (E), and (N) denote 100 µm. (P) Visual summary of the findings of the study. The panel was created with Inkscape v.1.4.2.
Induction With Thioglycolate Tgc Medium, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/situation+selection/Fusarium+compactum+(Wollenweber)+Raillo/pmc05790574-101-39-64
Average 90 stars, based on 1 article reviews
induction with thioglycolate tgc medium - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
a baumannii strain atcc 19606 t  (ATCC)
99
ATCC a baumannii strain atcc 19606 t
(A) Schematic drawing depicting the analysis of <t>CTEPH‐ECs,</t> HPAECs, and HSaVECs. The panel was created with BioRender.com. (B) TMEM100 mRNA expression in CTEPH‐ECs ( n = 20 biological replicates; ECs isolated from central PEA samples marked with “full” and distal PEA samples with “open” circles) compared to HPAECs ( n = 3 biological replicates examined in 3–6 independent experiments) and HSaVECs ( n = 1 biological replicate examined in four independent experiments). (C and D) TMEM100 protein expression in CTEPH‐ECs ( n = 3 biological replicates examined in 3 independent experiments), HPAECs ( n = 2 biological replicates examined in 2 – 3 independent experiments), and HSaVECs ( n = 1 biological replicate examined in 5 independent experiments). Quantitative analysis (C). Representative images (D). Expression of CD31/PECAM1 is shown to demonstrate EC marker expression. (E and F) Immunohistochemical detection of TMEM100 on cross‐sections through PEA specimens from patients with CTEPH ( n = 6 biological replicates) or PE ( n = 3 biological replicates examined in 2 independent experiments). Representative images (E). Quantitative analysis (F). Findings after omission of the first antibody (negative control) are also shown. ALK1 (G) and ALK5 (H) mRNA expression in CTEPH‐ECs ( n = 12 and n = 8 biological replicates, respectively) versus HPAECs ( n = 3 biological replicates examined in 2–3 independent experiments) and HSaVECs ( n = 1 biological replicate examined in 5 independent experiments). (I) TMEM100 mRNA expression in HPAECs ( n = 2 biological replicates examined in 2 independent experiments), control or after TGFβ1 stimulation (10 ng/mL for 24 h), alone or in the presence of the ALK1 inhibitor K02288 (10 µM) or the ALK5 inhibitor SB431542 (10 µM). ALK1 (J) and ALK5 (K) mRNA expression in HPAECs ( n = 2 biological replicates examined in 3 independent experiments), control or after TGFβ1 stimulation, and TMEM100 siRNA transfection. ALK1 (L) and ALK5 (M) mRNA expression in HPAECs ( n = 2 biological replicates examined in 2–3 independent experiments), alone or in the presence of an ALK5 (L) or ALK1 (M) inhibitor. Representative images (N) and quantitative analysis of the cumulative tube length (O) of CTEPH‐ECs ( n = 1 biological replicate examined in 4 independent experiments) cultivated on Matrigel for 5 h and the effects of TGFβ1 stimulation (10 ng/mL for 24 h), control or TMEM100 siRNA transfection, ALK1, or ALK5 inhibition. Exact p values were determined using unpaired Student's t ‐test (F, L, and M), one‐way ANOVA, Sidak's multiple comparisons test (G, H, I, and O), or Kruskal–Wallis, Dunn's multiple comparisons test (B, C, J, and K), based on the Shapiro–Wilk test for normal distribution. Quantitative data are shown as mean ± SEM or median with interquartile range, depending on the presence of normal distribution or not. Scale bars in (D), (E), and (N) denote 100 µm. (P) Visual summary of the findings of the study. The panel was created with Inkscape v.1.4.2.
A Baumannii Strain Atcc 19606 T, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/situation+selection/Acinetobacter+baumannii%3B+2208/pmc03554667-291-18-21
Average 99 stars, based on 1 article reviews
a baumannii strain atcc 19606 t - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier
samples ethics oversight thp 1 tib 202  (ATCC)
99
ATCC samples ethics oversight thp 1 tib 202
(A) Schematic drawing depicting the analysis of <t>CTEPH‐ECs,</t> HPAECs, and HSaVECs. The panel was created with BioRender.com. (B) TMEM100 mRNA expression in CTEPH‐ECs ( n = 20 biological replicates; ECs isolated from central PEA samples marked with “full” and distal PEA samples with “open” circles) compared to HPAECs ( n = 3 biological replicates examined in 3–6 independent experiments) and HSaVECs ( n = 1 biological replicate examined in four independent experiments). (C and D) TMEM100 protein expression in CTEPH‐ECs ( n = 3 biological replicates examined in 3 independent experiments), HPAECs ( n = 2 biological replicates examined in 2 – 3 independent experiments), and HSaVECs ( n = 1 biological replicate examined in 5 independent experiments). Quantitative analysis (C). Representative images (D). Expression of CD31/PECAM1 is shown to demonstrate EC marker expression. (E and F) Immunohistochemical detection of TMEM100 on cross‐sections through PEA specimens from patients with CTEPH ( n = 6 biological replicates) or PE ( n = 3 biological replicates examined in 2 independent experiments). Representative images (E). Quantitative analysis (F). Findings after omission of the first antibody (negative control) are also shown. ALK1 (G) and ALK5 (H) mRNA expression in CTEPH‐ECs ( n = 12 and n = 8 biological replicates, respectively) versus HPAECs ( n = 3 biological replicates examined in 2–3 independent experiments) and HSaVECs ( n = 1 biological replicate examined in 5 independent experiments). (I) TMEM100 mRNA expression in HPAECs ( n = 2 biological replicates examined in 2 independent experiments), control or after TGFβ1 stimulation (10 ng/mL for 24 h), alone or in the presence of the ALK1 inhibitor K02288 (10 µM) or the ALK5 inhibitor SB431542 (10 µM). ALK1 (J) and ALK5 (K) mRNA expression in HPAECs ( n = 2 biological replicates examined in 3 independent experiments), control or after TGFβ1 stimulation, and TMEM100 siRNA transfection. ALK1 (L) and ALK5 (M) mRNA expression in HPAECs ( n = 2 biological replicates examined in 2–3 independent experiments), alone or in the presence of an ALK5 (L) or ALK1 (M) inhibitor. Representative images (N) and quantitative analysis of the cumulative tube length (O) of CTEPH‐ECs ( n = 1 biological replicate examined in 4 independent experiments) cultivated on Matrigel for 5 h and the effects of TGFβ1 stimulation (10 ng/mL for 24 h), control or TMEM100 siRNA transfection, ALK1, or ALK5 inhibition. Exact p values were determined using unpaired Student's t ‐test (F, L, and M), one‐way ANOVA, Sidak's multiple comparisons test (G, H, I, and O), or Kruskal–Wallis, Dunn's multiple comparisons test (B, C, J, and K), based on the Shapiro–Wilk test for normal distribution. Quantitative data are shown as mean ± SEM or median with interquartile range, depending on the presence of normal distribution or not. Scale bars in (D), (E), and (N) denote 100 µm. (P) Visual summary of the findings of the study. The panel was created with Inkscape v.1.4.2.
Samples Ethics Oversight Thp 1 Tib 202, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/situation+selection/THP-1/pmc12501297__41467_2025_63905_MOESM2_ESM-100-51-63
Average 99 stars, based on 1 article reviews
samples ethics oversight thp 1 tib 202 - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier
ethics approval influenza a puerto rico 8 34  (ATCC)
98
ATCC ethics approval influenza a puerto rico 8 34
(A) Schematic drawing depicting the analysis of <t>CTEPH‐ECs,</t> HPAECs, and HSaVECs. The panel was created with BioRender.com. (B) TMEM100 mRNA expression in CTEPH‐ECs ( n = 20 biological replicates; ECs isolated from central PEA samples marked with “full” and distal PEA samples with “open” circles) compared to HPAECs ( n = 3 biological replicates examined in 3–6 independent experiments) and HSaVECs ( n = 1 biological replicate examined in four independent experiments). (C and D) TMEM100 protein expression in CTEPH‐ECs ( n = 3 biological replicates examined in 3 independent experiments), HPAECs ( n = 2 biological replicates examined in 2 – 3 independent experiments), and HSaVECs ( n = 1 biological replicate examined in 5 independent experiments). Quantitative analysis (C). Representative images (D). Expression of CD31/PECAM1 is shown to demonstrate EC marker expression. (E and F) Immunohistochemical detection of TMEM100 on cross‐sections through PEA specimens from patients with CTEPH ( n = 6 biological replicates) or PE ( n = 3 biological replicates examined in 2 independent experiments). Representative images (E). Quantitative analysis (F). Findings after omission of the first antibody (negative control) are also shown. ALK1 (G) and ALK5 (H) mRNA expression in CTEPH‐ECs ( n = 12 and n = 8 biological replicates, respectively) versus HPAECs ( n = 3 biological replicates examined in 2–3 independent experiments) and HSaVECs ( n = 1 biological replicate examined in 5 independent experiments). (I) TMEM100 mRNA expression in HPAECs ( n = 2 biological replicates examined in 2 independent experiments), control or after TGFβ1 stimulation (10 ng/mL for 24 h), alone or in the presence of the ALK1 inhibitor K02288 (10 µM) or the ALK5 inhibitor SB431542 (10 µM). ALK1 (J) and ALK5 (K) mRNA expression in HPAECs ( n = 2 biological replicates examined in 3 independent experiments), control or after TGFβ1 stimulation, and TMEM100 siRNA transfection. ALK1 (L) and ALK5 (M) mRNA expression in HPAECs ( n = 2 biological replicates examined in 2–3 independent experiments), alone or in the presence of an ALK5 (L) or ALK1 (M) inhibitor. Representative images (N) and quantitative analysis of the cumulative tube length (O) of CTEPH‐ECs ( n = 1 biological replicate examined in 4 independent experiments) cultivated on Matrigel for 5 h and the effects of TGFβ1 stimulation (10 ng/mL for 24 h), control or TMEM100 siRNA transfection, ALK1, or ALK5 inhibition. Exact p values were determined using unpaired Student's t ‐test (F, L, and M), one‐way ANOVA, Sidak's multiple comparisons test (G, H, I, and O), or Kruskal–Wallis, Dunn's multiple comparisons test (B, C, J, and K), based on the Shapiro–Wilk test for normal distribution. Quantitative data are shown as mean ± SEM or median with interquartile range, depending on the presence of normal distribution or not. Scale bars in (D), (E), and (N) denote 100 µm. (P) Visual summary of the findings of the study. The panel was created with Inkscape v.1.4.2.
Ethics Approval Influenza A Puerto Rico 8 34, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/situation+selection/Influenza+A+virus/pmc05745522-49-3-13
Average 98 stars, based on 1 article reviews
ethics approval influenza a puerto rico 8 34 - by Bioz Stars, 2026-10
98/100 stars
  Buy from Supplier
reference strain atcc 27768  (ATCC)
95
ATCC reference strain atcc 27768
(A) Schematic drawing depicting the analysis of <t>CTEPH‐ECs,</t> HPAECs, and HSaVECs. The panel was created with BioRender.com. (B) TMEM100 mRNA expression in CTEPH‐ECs ( n = 20 biological replicates; ECs isolated from central PEA samples marked with “full” and distal PEA samples with “open” circles) compared to HPAECs ( n = 3 biological replicates examined in 3–6 independent experiments) and HSaVECs ( n = 1 biological replicate examined in four independent experiments). (C and D) TMEM100 protein expression in CTEPH‐ECs ( n = 3 biological replicates examined in 3 independent experiments), HPAECs ( n = 2 biological replicates examined in 2 – 3 independent experiments), and HSaVECs ( n = 1 biological replicate examined in 5 independent experiments). Quantitative analysis (C). Representative images (D). Expression of CD31/PECAM1 is shown to demonstrate EC marker expression. (E and F) Immunohistochemical detection of TMEM100 on cross‐sections through PEA specimens from patients with CTEPH ( n = 6 biological replicates) or PE ( n = 3 biological replicates examined in 2 independent experiments). Representative images (E). Quantitative analysis (F). Findings after omission of the first antibody (negative control) are also shown. ALK1 (G) and ALK5 (H) mRNA expression in CTEPH‐ECs ( n = 12 and n = 8 biological replicates, respectively) versus HPAECs ( n = 3 biological replicates examined in 2–3 independent experiments) and HSaVECs ( n = 1 biological replicate examined in 5 independent experiments). (I) TMEM100 mRNA expression in HPAECs ( n = 2 biological replicates examined in 2 independent experiments), control or after TGFβ1 stimulation (10 ng/mL for 24 h), alone or in the presence of the ALK1 inhibitor K02288 (10 µM) or the ALK5 inhibitor SB431542 (10 µM). ALK1 (J) and ALK5 (K) mRNA expression in HPAECs ( n = 2 biological replicates examined in 3 independent experiments), control or after TGFβ1 stimulation, and TMEM100 siRNA transfection. ALK1 (L) and ALK5 (M) mRNA expression in HPAECs ( n = 2 biological replicates examined in 2–3 independent experiments), alone or in the presence of an ALK5 (L) or ALK1 (M) inhibitor. Representative images (N) and quantitative analysis of the cumulative tube length (O) of CTEPH‐ECs ( n = 1 biological replicate examined in 4 independent experiments) cultivated on Matrigel for 5 h and the effects of TGFβ1 stimulation (10 ng/mL for 24 h), control or TMEM100 siRNA transfection, ALK1, or ALK5 inhibition. Exact p values were determined using unpaired Student's t ‐test (F, L, and M), one‐way ANOVA, Sidak's multiple comparisons test (G, H, I, and O), or Kruskal–Wallis, Dunn's multiple comparisons test (B, C, J, and K), based on the Shapiro–Wilk test for normal distribution. Quantitative data are shown as mean ± SEM or median with interquartile range, depending on the presence of normal distribution or not. Scale bars in (D), (E), and (N) denote 100 µm. (P) Visual summary of the findings of the study. The panel was created with Inkscape v.1.4.2.
Reference Strain Atcc 27768, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/situation+selection/Faecalibacterium+prausnitzii%3B+Strain%3A+VPI+C13-51/us10799540-189-13-15
Average 95 stars, based on 1 article reviews
reference strain atcc 27768 - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier
type situation sbg1 4201 bp 3678 bp sbg2 4199 bp 3451 bp sbg3 4199 bp 2839 bp sbg4 4190 bp 5950 bp sbg5 4201 bp 3360 bp  (ATCC)
94
ATCC type situation sbg1 4201 bp 3678 bp sbg2 4199 bp 3451 bp sbg3 4199 bp 2839 bp sbg4 4190 bp 5950 bp sbg5 4201 bp 3360 bp
(A) Schematic drawing depicting the analysis of <t>CTEPH‐ECs,</t> HPAECs, and HSaVECs. The panel was created with BioRender.com. (B) TMEM100 mRNA expression in CTEPH‐ECs ( n = 20 biological replicates; ECs isolated from central PEA samples marked with “full” and distal PEA samples with “open” circles) compared to HPAECs ( n = 3 biological replicates examined in 3–6 independent experiments) and HSaVECs ( n = 1 biological replicate examined in four independent experiments). (C and D) TMEM100 protein expression in CTEPH‐ECs ( n = 3 biological replicates examined in 3 independent experiments), HPAECs ( n = 2 biological replicates examined in 2 – 3 independent experiments), and HSaVECs ( n = 1 biological replicate examined in 5 independent experiments). Quantitative analysis (C). Representative images (D). Expression of CD31/PECAM1 is shown to demonstrate EC marker expression. (E and F) Immunohistochemical detection of TMEM100 on cross‐sections through PEA specimens from patients with CTEPH ( n = 6 biological replicates) or PE ( n = 3 biological replicates examined in 2 independent experiments). Representative images (E). Quantitative analysis (F). Findings after omission of the first antibody (negative control) are also shown. ALK1 (G) and ALK5 (H) mRNA expression in CTEPH‐ECs ( n = 12 and n = 8 biological replicates, respectively) versus HPAECs ( n = 3 biological replicates examined in 2–3 independent experiments) and HSaVECs ( n = 1 biological replicate examined in 5 independent experiments). (I) TMEM100 mRNA expression in HPAECs ( n = 2 biological replicates examined in 2 independent experiments), control or after TGFβ1 stimulation (10 ng/mL for 24 h), alone or in the presence of the ALK1 inhibitor K02288 (10 µM) or the ALK5 inhibitor SB431542 (10 µM). ALK1 (J) and ALK5 (K) mRNA expression in HPAECs ( n = 2 biological replicates examined in 3 independent experiments), control or after TGFβ1 stimulation, and TMEM100 siRNA transfection. ALK1 (L) and ALK5 (M) mRNA expression in HPAECs ( n = 2 biological replicates examined in 2–3 independent experiments), alone or in the presence of an ALK5 (L) or ALK1 (M) inhibitor. Representative images (N) and quantitative analysis of the cumulative tube length (O) of CTEPH‐ECs ( n = 1 biological replicate examined in 4 independent experiments) cultivated on Matrigel for 5 h and the effects of TGFβ1 stimulation (10 ng/mL for 24 h), control or TMEM100 siRNA transfection, ALK1, or ALK5 inhibition. Exact p values were determined using unpaired Student's t ‐test (F, L, and M), one‐way ANOVA, Sidak's multiple comparisons test (G, H, I, and O), or Kruskal–Wallis, Dunn's multiple comparisons test (B, C, J, and K), based on the Shapiro–Wilk test for normal distribution. Quantitative data are shown as mean ± SEM or median with interquartile range, depending on the presence of normal distribution or not. Scale bars in (D), (E), and (N) denote 100 µm. (P) Visual summary of the findings of the study. The panel was created with Inkscape v.1.4.2.
Type Situation Sbg1 4201 Bp 3678 Bp Sbg2 4199 Bp 3451 Bp Sbg3 4199 Bp 2839 Bp Sbg4 4190 Bp 5950 Bp Sbg5 4201 Bp 3360 Bp, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/situation+selection/SA13/us08911982-294-16-57
Average 94 stars, based on 1 article reviews
type situation sbg1 4201 bp 3678 bp sbg2 4199 bp 3451 bp sbg3 4199 bp 2839 bp sbg4 4190 bp 5950 bp sbg5 4201 bp 3360 bp - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier
ethics approval tt  (ATCC)
96
ATCC ethics approval tt
(A) Schematic drawing depicting the analysis of <t>CTEPH‐ECs,</t> HPAECs, and HSaVECs. The panel was created with BioRender.com. (B) TMEM100 mRNA expression in CTEPH‐ECs ( n = 20 biological replicates; ECs isolated from central PEA samples marked with “full” and distal PEA samples with “open” circles) compared to HPAECs ( n = 3 biological replicates examined in 3–6 independent experiments) and HSaVECs ( n = 1 biological replicate examined in four independent experiments). (C and D) TMEM100 protein expression in CTEPH‐ECs ( n = 3 biological replicates examined in 3 independent experiments), HPAECs ( n = 2 biological replicates examined in 2 – 3 independent experiments), and HSaVECs ( n = 1 biological replicate examined in 5 independent experiments). Quantitative analysis (C). Representative images (D). Expression of CD31/PECAM1 is shown to demonstrate EC marker expression. (E and F) Immunohistochemical detection of TMEM100 on cross‐sections through PEA specimens from patients with CTEPH ( n = 6 biological replicates) or PE ( n = 3 biological replicates examined in 2 independent experiments). Representative images (E). Quantitative analysis (F). Findings after omission of the first antibody (negative control) are also shown. ALK1 (G) and ALK5 (H) mRNA expression in CTEPH‐ECs ( n = 12 and n = 8 biological replicates, respectively) versus HPAECs ( n = 3 biological replicates examined in 2–3 independent experiments) and HSaVECs ( n = 1 biological replicate examined in 5 independent experiments). (I) TMEM100 mRNA expression in HPAECs ( n = 2 biological replicates examined in 2 independent experiments), control or after TGFβ1 stimulation (10 ng/mL for 24 h), alone or in the presence of the ALK1 inhibitor K02288 (10 µM) or the ALK5 inhibitor SB431542 (10 µM). ALK1 (J) and ALK5 (K) mRNA expression in HPAECs ( n = 2 biological replicates examined in 3 independent experiments), control or after TGFβ1 stimulation, and TMEM100 siRNA transfection. ALK1 (L) and ALK5 (M) mRNA expression in HPAECs ( n = 2 biological replicates examined in 2–3 independent experiments), alone or in the presence of an ALK5 (L) or ALK1 (M) inhibitor. Representative images (N) and quantitative analysis of the cumulative tube length (O) of CTEPH‐ECs ( n = 1 biological replicate examined in 4 independent experiments) cultivated on Matrigel for 5 h and the effects of TGFβ1 stimulation (10 ng/mL for 24 h), control or TMEM100 siRNA transfection, ALK1, or ALK5 inhibition. Exact p values were determined using unpaired Student's t ‐test (F, L, and M), one‐way ANOVA, Sidak's multiple comparisons test (G, H, I, and O), or Kruskal–Wallis, Dunn's multiple comparisons test (B, C, J, and K), based on the Shapiro–Wilk test for normal distribution. Quantitative data are shown as mean ± SEM or median with interquartile range, depending on the presence of normal distribution or not. Scale bars in (D), (E), and (N) denote 100 µm. (P) Visual summary of the findings of the study. The panel was created with Inkscape v.1.4.2.
Ethics Approval Tt, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/situation+selection/MES-SA%2FMX2%3B+Uterine+Sarcoma%3B+Human/pm38689139-194-0-3
Average 96 stars, based on 1 article reviews
ethics approval tt - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier
whisker motor cortex  (World Precision Instruments)
93
World Precision Instruments whisker motor cortex
(A) Schematic drawing depicting the analysis of <t>CTEPH‐ECs,</t> HPAECs, and HSaVECs. The panel was created with BioRender.com. (B) TMEM100 mRNA expression in CTEPH‐ECs ( n = 20 biological replicates; ECs isolated from central PEA samples marked with “full” and distal PEA samples with “open” circles) compared to HPAECs ( n = 3 biological replicates examined in 3–6 independent experiments) and HSaVECs ( n = 1 biological replicate examined in four independent experiments). (C and D) TMEM100 protein expression in CTEPH‐ECs ( n = 3 biological replicates examined in 3 independent experiments), HPAECs ( n = 2 biological replicates examined in 2 – 3 independent experiments), and HSaVECs ( n = 1 biological replicate examined in 5 independent experiments). Quantitative analysis (C). Representative images (D). Expression of CD31/PECAM1 is shown to demonstrate EC marker expression. (E and F) Immunohistochemical detection of TMEM100 on cross‐sections through PEA specimens from patients with CTEPH ( n = 6 biological replicates) or PE ( n = 3 biological replicates examined in 2 independent experiments). Representative images (E). Quantitative analysis (F). Findings after omission of the first antibody (negative control) are also shown. ALK1 (G) and ALK5 (H) mRNA expression in CTEPH‐ECs ( n = 12 and n = 8 biological replicates, respectively) versus HPAECs ( n = 3 biological replicates examined in 2–3 independent experiments) and HSaVECs ( n = 1 biological replicate examined in 5 independent experiments). (I) TMEM100 mRNA expression in HPAECs ( n = 2 biological replicates examined in 2 independent experiments), control or after TGFβ1 stimulation (10 ng/mL for 24 h), alone or in the presence of the ALK1 inhibitor K02288 (10 µM) or the ALK5 inhibitor SB431542 (10 µM). ALK1 (J) and ALK5 (K) mRNA expression in HPAECs ( n = 2 biological replicates examined in 3 independent experiments), control or after TGFβ1 stimulation, and TMEM100 siRNA transfection. ALK1 (L) and ALK5 (M) mRNA expression in HPAECs ( n = 2 biological replicates examined in 2–3 independent experiments), alone or in the presence of an ALK5 (L) or ALK1 (M) inhibitor. Representative images (N) and quantitative analysis of the cumulative tube length (O) of CTEPH‐ECs ( n = 1 biological replicate examined in 4 independent experiments) cultivated on Matrigel for 5 h and the effects of TGFβ1 stimulation (10 ng/mL for 24 h), control or TMEM100 siRNA transfection, ALK1, or ALK5 inhibition. Exact p values were determined using unpaired Student's t ‐test (F, L, and M), one‐way ANOVA, Sidak's multiple comparisons test (G, H, I, and O), or Kruskal–Wallis, Dunn's multiple comparisons test (B, C, J, and K), based on the Shapiro–Wilk test for normal distribution. Quantitative data are shown as mean ± SEM or median with interquartile range, depending on the presence of normal distribution or not. Scale bars in (D), (E), and (N) denote 100 µm. (P) Visual summary of the findings of the study. The panel was created with Inkscape v.1.4.2.
Whisker Motor Cortex, supplied by World Precision Instruments, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/situation+selection/Manipulator+Mounting+Clamp/pmc05623691-59-29-8
Average 93 stars, based on 1 article reviews
whisker motor cortex - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier
lacticaseibacillus rhamnosus gg atcc 53103 strain  (ATCC)
99
ATCC lacticaseibacillus rhamnosus gg atcc 53103 strain
(A) Schematic drawing depicting the analysis of <t>CTEPH‐ECs,</t> HPAECs, and HSaVECs. The panel was created with BioRender.com. (B) TMEM100 mRNA expression in CTEPH‐ECs ( n = 20 biological replicates; ECs isolated from central PEA samples marked with “full” and distal PEA samples with “open” circles) compared to HPAECs ( n = 3 biological replicates examined in 3–6 independent experiments) and HSaVECs ( n = 1 biological replicate examined in four independent experiments). (C and D) TMEM100 protein expression in CTEPH‐ECs ( n = 3 biological replicates examined in 3 independent experiments), HPAECs ( n = 2 biological replicates examined in 2 – 3 independent experiments), and HSaVECs ( n = 1 biological replicate examined in 5 independent experiments). Quantitative analysis (C). Representative images (D). Expression of CD31/PECAM1 is shown to demonstrate EC marker expression. (E and F) Immunohistochemical detection of TMEM100 on cross‐sections through PEA specimens from patients with CTEPH ( n = 6 biological replicates) or PE ( n = 3 biological replicates examined in 2 independent experiments). Representative images (E). Quantitative analysis (F). Findings after omission of the first antibody (negative control) are also shown. ALK1 (G) and ALK5 (H) mRNA expression in CTEPH‐ECs ( n = 12 and n = 8 biological replicates, respectively) versus HPAECs ( n = 3 biological replicates examined in 2–3 independent experiments) and HSaVECs ( n = 1 biological replicate examined in 5 independent experiments). (I) TMEM100 mRNA expression in HPAECs ( n = 2 biological replicates examined in 2 independent experiments), control or after TGFβ1 stimulation (10 ng/mL for 24 h), alone or in the presence of the ALK1 inhibitor K02288 (10 µM) or the ALK5 inhibitor SB431542 (10 µM). ALK1 (J) and ALK5 (K) mRNA expression in HPAECs ( n = 2 biological replicates examined in 3 independent experiments), control or after TGFβ1 stimulation, and TMEM100 siRNA transfection. ALK1 (L) and ALK5 (M) mRNA expression in HPAECs ( n = 2 biological replicates examined in 2–3 independent experiments), alone or in the presence of an ALK5 (L) or ALK1 (M) inhibitor. Representative images (N) and quantitative analysis of the cumulative tube length (O) of CTEPH‐ECs ( n = 1 biological replicate examined in 4 independent experiments) cultivated on Matrigel for 5 h and the effects of TGFβ1 stimulation (10 ng/mL for 24 h), control or TMEM100 siRNA transfection, ALK1, or ALK5 inhibition. Exact p values were determined using unpaired Student's t ‐test (F, L, and M), one‐way ANOVA, Sidak's multiple comparisons test (G, H, I, and O), or Kruskal–Wallis, Dunn's multiple comparisons test (B, C, J, and K), based on the Shapiro–Wilk test for normal distribution. Quantitative data are shown as mean ± SEM or median with interquartile range, depending on the presence of normal distribution or not. Scale bars in (D), (E), and (N) denote 100 µm. (P) Visual summary of the findings of the study. The panel was created with Inkscape v.1.4.2.
Lacticaseibacillus Rhamnosus Gg Atcc 53103 Strain, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/situation+selection/Lacticaseibacillus+rhamnosus%3B+Strain+GG/pm37446871-235-7-10
Average 99 stars, based on 1 article reviews
lacticaseibacillus rhamnosus gg atcc 53103 strain - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier
ethics approval thyroid medullary carcinoma tt cell line  (ATCC)
97
ATCC ethics approval thyroid medullary carcinoma tt cell line
(A) Schematic drawing depicting the analysis of <t>CTEPH‐ECs,</t> HPAECs, and HSaVECs. The panel was created with BioRender.com. (B) TMEM100 mRNA expression in CTEPH‐ECs ( n = 20 biological replicates; ECs isolated from central PEA samples marked with “full” and distal PEA samples with “open” circles) compared to HPAECs ( n = 3 biological replicates examined in 3–6 independent experiments) and HSaVECs ( n = 1 biological replicate examined in four independent experiments). (C and D) TMEM100 protein expression in CTEPH‐ECs ( n = 3 biological replicates examined in 3 independent experiments), HPAECs ( n = 2 biological replicates examined in 2 – 3 independent experiments), and HSaVECs ( n = 1 biological replicate examined in 5 independent experiments). Quantitative analysis (C). Representative images (D). Expression of CD31/PECAM1 is shown to demonstrate EC marker expression. (E and F) Immunohistochemical detection of TMEM100 on cross‐sections through PEA specimens from patients with CTEPH ( n = 6 biological replicates) or PE ( n = 3 biological replicates examined in 2 independent experiments). Representative images (E). Quantitative analysis (F). Findings after omission of the first antibody (negative control) are also shown. ALK1 (G) and ALK5 (H) mRNA expression in CTEPH‐ECs ( n = 12 and n = 8 biological replicates, respectively) versus HPAECs ( n = 3 biological replicates examined in 2–3 independent experiments) and HSaVECs ( n = 1 biological replicate examined in 5 independent experiments). (I) TMEM100 mRNA expression in HPAECs ( n = 2 biological replicates examined in 2 independent experiments), control or after TGFβ1 stimulation (10 ng/mL for 24 h), alone or in the presence of the ALK1 inhibitor K02288 (10 µM) or the ALK5 inhibitor SB431542 (10 µM). ALK1 (J) and ALK5 (K) mRNA expression in HPAECs ( n = 2 biological replicates examined in 3 independent experiments), control or after TGFβ1 stimulation, and TMEM100 siRNA transfection. ALK1 (L) and ALK5 (M) mRNA expression in HPAECs ( n = 2 biological replicates examined in 2–3 independent experiments), alone or in the presence of an ALK5 (L) or ALK1 (M) inhibitor. Representative images (N) and quantitative analysis of the cumulative tube length (O) of CTEPH‐ECs ( n = 1 biological replicate examined in 4 independent experiments) cultivated on Matrigel for 5 h and the effects of TGFβ1 stimulation (10 ng/mL for 24 h), control or TMEM100 siRNA transfection, ALK1, or ALK5 inhibition. Exact p values were determined using unpaired Student's t ‐test (F, L, and M), one‐way ANOVA, Sidak's multiple comparisons test (G, H, I, and O), or Kruskal–Wallis, Dunn's multiple comparisons test (B, C, J, and K), based on the Shapiro–Wilk test for normal distribution. Quantitative data are shown as mean ± SEM or median with interquartile range, depending on the presence of normal distribution or not. Scale bars in (D), (E), and (N) denote 100 µm. (P) Visual summary of the findings of the study. The panel was created with Inkscape v.1.4.2.
Ethics Approval Thyroid Medullary Carcinoma Tt Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/situation+selection/TIBx%3B+Epithelial+liver%3B+Mouse/ppr0812357-191-0-8
Average 97 stars, based on 1 article reviews
ethics approval thyroid medullary carcinoma tt cell line - by Bioz Stars, 2026-10
97/100 stars
  Buy from Supplier

Image Search Results


(A) Schematic drawing depicting the analysis of CTEPH‐ECs, HPAECs, and HSaVECs. The panel was created with BioRender.com. (B) TMEM100 mRNA expression in CTEPH‐ECs ( n = 20 biological replicates; ECs isolated from central PEA samples marked with “full” and distal PEA samples with “open” circles) compared to HPAECs ( n = 3 biological replicates examined in 3–6 independent experiments) and HSaVECs ( n = 1 biological replicate examined in four independent experiments). (C and D) TMEM100 protein expression in CTEPH‐ECs ( n = 3 biological replicates examined in 3 independent experiments), HPAECs ( n = 2 biological replicates examined in 2 – 3 independent experiments), and HSaVECs ( n = 1 biological replicate examined in 5 independent experiments). Quantitative analysis (C). Representative images (D). Expression of CD31/PECAM1 is shown to demonstrate EC marker expression. (E and F) Immunohistochemical detection of TMEM100 on cross‐sections through PEA specimens from patients with CTEPH ( n = 6 biological replicates) or PE ( n = 3 biological replicates examined in 2 independent experiments). Representative images (E). Quantitative analysis (F). Findings after omission of the first antibody (negative control) are also shown. ALK1 (G) and ALK5 (H) mRNA expression in CTEPH‐ECs ( n = 12 and n = 8 biological replicates, respectively) versus HPAECs ( n = 3 biological replicates examined in 2–3 independent experiments) and HSaVECs ( n = 1 biological replicate examined in 5 independent experiments). (I) TMEM100 mRNA expression in HPAECs ( n = 2 biological replicates examined in 2 independent experiments), control or after TGFβ1 stimulation (10 ng/mL for 24 h), alone or in the presence of the ALK1 inhibitor K02288 (10 µM) or the ALK5 inhibitor SB431542 (10 µM). ALK1 (J) and ALK5 (K) mRNA expression in HPAECs ( n = 2 biological replicates examined in 3 independent experiments), control or after TGFβ1 stimulation, and TMEM100 siRNA transfection. ALK1 (L) and ALK5 (M) mRNA expression in HPAECs ( n = 2 biological replicates examined in 2–3 independent experiments), alone or in the presence of an ALK5 (L) or ALK1 (M) inhibitor. Representative images (N) and quantitative analysis of the cumulative tube length (O) of CTEPH‐ECs ( n = 1 biological replicate examined in 4 independent experiments) cultivated on Matrigel for 5 h and the effects of TGFβ1 stimulation (10 ng/mL for 24 h), control or TMEM100 siRNA transfection, ALK1, or ALK5 inhibition. Exact p values were determined using unpaired Student's t ‐test (F, L, and M), one‐way ANOVA, Sidak's multiple comparisons test (G, H, I, and O), or Kruskal–Wallis, Dunn's multiple comparisons test (B, C, J, and K), based on the Shapiro–Wilk test for normal distribution. Quantitative data are shown as mean ± SEM or median with interquartile range, depending on the presence of normal distribution or not. Scale bars in (D), (E), and (N) denote 100 µm. (P) Visual summary of the findings of the study. The panel was created with Inkscape v.1.4.2.

Journal: Pulmonary Circulation

Article Title: Transmembrane Protein 100 Expression on Endothelial Cells Vascularizing Thrombi in Chronic Thromboembolic Pulmonary Hypertension Modulates TGFβ1−ALK1 Signaling During Angiogenesis

doi: 10.1002/pul2.70253

Figure Lengend Snippet: (A) Schematic drawing depicting the analysis of CTEPH‐ECs, HPAECs, and HSaVECs. The panel was created with BioRender.com. (B) TMEM100 mRNA expression in CTEPH‐ECs ( n = 20 biological replicates; ECs isolated from central PEA samples marked with “full” and distal PEA samples with “open” circles) compared to HPAECs ( n = 3 biological replicates examined in 3–6 independent experiments) and HSaVECs ( n = 1 biological replicate examined in four independent experiments). (C and D) TMEM100 protein expression in CTEPH‐ECs ( n = 3 biological replicates examined in 3 independent experiments), HPAECs ( n = 2 biological replicates examined in 2 – 3 independent experiments), and HSaVECs ( n = 1 biological replicate examined in 5 independent experiments). Quantitative analysis (C). Representative images (D). Expression of CD31/PECAM1 is shown to demonstrate EC marker expression. (E and F) Immunohistochemical detection of TMEM100 on cross‐sections through PEA specimens from patients with CTEPH ( n = 6 biological replicates) or PE ( n = 3 biological replicates examined in 2 independent experiments). Representative images (E). Quantitative analysis (F). Findings after omission of the first antibody (negative control) are also shown. ALK1 (G) and ALK5 (H) mRNA expression in CTEPH‐ECs ( n = 12 and n = 8 biological replicates, respectively) versus HPAECs ( n = 3 biological replicates examined in 2–3 independent experiments) and HSaVECs ( n = 1 biological replicate examined in 5 independent experiments). (I) TMEM100 mRNA expression in HPAECs ( n = 2 biological replicates examined in 2 independent experiments), control or after TGFβ1 stimulation (10 ng/mL for 24 h), alone or in the presence of the ALK1 inhibitor K02288 (10 µM) or the ALK5 inhibitor SB431542 (10 µM). ALK1 (J) and ALK5 (K) mRNA expression in HPAECs ( n = 2 biological replicates examined in 3 independent experiments), control or after TGFβ1 stimulation, and TMEM100 siRNA transfection. ALK1 (L) and ALK5 (M) mRNA expression in HPAECs ( n = 2 biological replicates examined in 2–3 independent experiments), alone or in the presence of an ALK5 (L) or ALK1 (M) inhibitor. Representative images (N) and quantitative analysis of the cumulative tube length (O) of CTEPH‐ECs ( n = 1 biological replicate examined in 4 independent experiments) cultivated on Matrigel for 5 h and the effects of TGFβ1 stimulation (10 ng/mL for 24 h), control or TMEM100 siRNA transfection, ALK1, or ALK5 inhibition. Exact p values were determined using unpaired Student's t ‐test (F, L, and M), one‐way ANOVA, Sidak's multiple comparisons test (G, H, I, and O), or Kruskal–Wallis, Dunn's multiple comparisons test (B, C, J, and K), based on the Shapiro–Wilk test for normal distribution. Quantitative data are shown as mean ± SEM or median with interquartile range, depending on the presence of normal distribution or not. Scale bars in (D), (E), and (N) denote 100 µm. (P) Visual summary of the findings of the study. The panel was created with Inkscape v.1.4.2.

Article Snippet: CTEPH‐ECs (Passage 1; Ethics Approval AZ 199/15) were isolated from CTEPH PEA specimens, as described in Bochenek et al. [ ], and compared to human pulmonary arterial ECs (HPAECs; PromoCell, C‐12241, Lot Numbers 458Z016.13 and 482Z007.13; ATCC, PCS‐100‐022, Lot Number 59880292) and ECs from the human saphenous vein (HSaVECs; PromoCell, C‐12231, Lot Number 455Z015.1), a frequent origin of blood clots embolizing into the lungs.

Techniques: Expressing, Isolation, Marker, Immunohistochemical staining, Negative Control, Control, Transfection, Inhibition